20例非酒精性脂肪性肝硬化的临床特征分析

李磊; 丁惠国

20例非酒精性脂肪性肝硬化的临床特征分析

李磊,
丁惠国

首都医科大学附属北京佑安医院消化科

基金项目:

中国肝炎防治基金会王宝恩肝纤维化基金(20100021)；

详细信息

中图分类号: R575.5
计量
- 文章访问数: 3205
- HTML全文浏览量: 17
- PDF下载量: 687
- 被引次数: 0
出版历程
- 出版日期: 2011-10-20

Clinical features of cirrhosis due to nonalcoholic steatohepatitis

Li Lei,
Ding HuiGuo

Research funding:

摘要

摘要: 目的探讨非酒精性脂肪性肝硬化的临床特征。方法回顾性分析20例非酒精性脂肪性肝硬化初治住院患者的临床资料,以30例乙型肝炎肝硬化初治住院患者作为对照,记录患者性别、年龄、血糖、血脂、白细胞、血小板、凝血酶原活动度、凝血酶原国际标准化比率、总胆红素、白蛋白、胆碱脂酶、尿素氮、肌酐、电解质(血钾、钠、氯)、腹部超声及胃镜等临床数据,计算MELD评分,比较两组间的差异。结果非酒精性脂肪性肝硬化组平均年龄为(69.15±13.84)岁,明显高于对照组[(48.67±15.09)岁,P=0.021];男性占35%(7/20),女性占65%(13/20),对照组男性占80%(24/30),女性占20%(6/30);高血压、糖尿病及血脂紊乱的发病率分别为60%(12/20)、75%(15/20)和55%(11/20),明显高于对照组(分别为16.7%、46.7%和10%,P=0.008、0.015、0.041);凝血酶原活动度为(75.26±8.57)%,明显高于对照组[(52.37±10.86)%,P=0.038],凝血酶原国际标准化比率为1.03±0.25,显著低于对照组(1.44±0.31,P=...
- 脂肪肝 /
- 肝硬化 /
- 肝炎,乙型
Abstract: Objective This study aims to investigate the clinical features of cirrhosis due to nonalcoholic steatohepatitis.Methods Clinical data of twenty patients diagnosed as cirrhosis due to nonalcoholic steatohepatitis was retrospectively analyzed and compared with thirty patients diagnosed as cirrhosis due to hepatitis B.The index including gender, age, blood sugar, blood fat, WBC, platelet, PTA%, INR, TBil, albumin, choline phospholipid, urea nitrogen, creatinine, electrolyte, AFP, abdomen ultrasound and gastroscopy report was recorded.MELD score was calculated.The difference of data between two groups was compared.Results The average age in the group of cirrhosis due to nonalcoholic steatohepatitis is (69.15±13.84) years, which is older than that in control group [ (48.67±15.09) years, P=0.021].Male accounts 35% (7/20) and female accounts 65% (13/20) , while in control group male accounts 80% (24/30) and female accounts 20% (6/30) .Morbidity of hypertension, diabetes and hyperlipemia is higher than that in control group (respectively 60%vs 16.7%, 75%vs 46.7%, 55%vs 10%, P=0.008, 0.015, 0.041) .PTA% is significantly higher than that in control group [ (75.26±8.57) % vs (52.37±10.86) %, P=0.038) ].INR was obviously lower than that in control group [ (1.03±0.25) vs (1.44±0.31) , P=0.042].Incidence of electrolyte disturbances was 5% (1/20) , which is significantly lower than that in control group 63.3% (19/30, P=0.023) .MELD score is obviously lower than that in control group [ (7.69±3.46) vs (16.54±9.50) , P=0.002].Conclusion The clinical features of cirrhosis due to nonalcoholic steatohepatitis were listed as following: (1) older age; (2) more common in female than male; (3) higher morbidity due to hypertension, diabetes and hyperlipemia; (4) better liver function and kidney function; (5) less such complications as electrolyte disturbances and hepatorenal syndrome; (6) better prognosis; (7) portal hypertension manifestations such as hypersplenism, EV and ascitis are similar to cirrhosis due to hepatitis B.
- fatty liver /
- liver cirrhosis /
- hepatitis B

HTML全文

参考文献(14)

[1]Fan JG, Farrell GC.Epidemiology of non-alcoholic fatty liverdisease in China[J].J Hepatol, 2009, 50 (1) :204-210.

[2]de Alwis NM, Day CP.Non-alcoholic fatty liver disease:the mist gradually clears[J].J Hepatol, 2008, 48 (Suppl 1) :S104-S112.

[3]Farrell GC, Chitturi S, Lau GK, et al.Guidelines for the as-sessment and management of non-alcoholic fatty liver dis-ease in the Asia-Pacific region:executive summary[J].JGastroenterol Hepatol, 2007, 22 (6) :775-777.

[4]中华医学会.病毒性肝炎防治方案[J].中华肝脏病杂志, 2000, 8 (6) :324-329.

[5]Zeng MD, Fan JG, Lu LG, et al.Guidelines for the diagnosisand treatment of nonalcoholic fatty liver disease[J].DigDis, 2008, 9 (2) :108-122.

[6] 中华医学会.消化道静脉曲张及出血的内镜诊断和治疗规范试行方案 (2009年) [J].中华消化内镜杂志, 2010, 27 (1) :1-4.

[7]施丁一, 刘华, 陈健.腹腔积液声像769例特征分析[J].武警医学, 1998, 9 (4) :196-198.

[8]Angulo P.GI epidemiology:nonalcoholic fatty liver disease[J].Aliment Pharmacol Ther, 2007, 25 (8) :883-889.

[9]Fan JG, Zhu J, Li XJ, et al.Prevalence of and risk factorsfor fatty liver in a general population of Shanghai, China[J].J Hepatol, 2005, 43 (3) :508-514.

[10]Fan JG, Saibara T, Chitturi S, et al.What are the risk factorsand settings for non-alcoholic fatty liver disease in Asia-Pacific?[J].J Gastroenterol Hepatol, 2007, 22 (6) :794-880.

[11]Farrell GC, Larter CZ.Nonalcoholic fatty liver disease:fromsteatosis to cirrhosis[J].Hepatology, 2006, 43 (2 Suppl1) :S99-S112.

[12]徐正婕, 钟妍, 范建高.上海地区494例肝硬化的病因及其与糖代谢异常的关系[J].中华肝脏病杂志, 2009, 17 (6) :470-471.

[13]Smith B, Georage J.A dipocyte-hepatocyte crosstalk andthe pathogenesis of nonalcoholic fatty liver disease[J].Hep-atology, 2009, 49 (5) :1765-1767.

[14]Lalor PF, Faint J, Aarbodem Y, et al.The role of cytokinesand chemokines in the development of steatohepatitis[J].Seminar in liver disease, 2007, 27 (2) :173-193.

施引文献

资源附件(0)

访问统计